0001209191-22-039057.txt : 20220623
0001209191-22-039057.hdr.sgml : 20220623
20220623195635
ACCESSION NUMBER: 0001209191-22-039057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220621
FILED AS OF DATE: 20220623
DATE AS OF CHANGE: 20220623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Nora
CENTRAL INDEX KEY: 0001790215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 221036707
MAIL ADDRESS:
STREET 1: C/O TELA BIO, INC.
STREET 2: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-21
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001790215
Brennan Nora
11500 S. EASTERN AVE.
SUITE 220
HENDERSON
NV
89052
0
1
0
0
EVP & CFO
Common Stock, $0.001 par value
2022-06-21
4
A
0
334507
0.00
A
363784
D
Common Stock, $0.001 par value
2022-06-21
4
S
0
3569
0.785
D
360215
D
Stock Option (Right to Buy)
0.71
2022-06-21
4
A
0
1515957
0.00
A
2032-05-25
Common Stock
1515957
1515957
D
The restricted stock unit grant was approved by Spectrum Pharmaceuticals, Inc's ("Spectrum") board of directors on May 25, 2022, subject to stockholder approval of the Amended and Restated 2018 Long-Term Incentive Plan (the "Plan") under which the restricted stock unit was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
The option grant was approved by Spectrum's board of directors on May 25, 2022, subject to stockholder approval of the Plan under which the option was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
One third of the aggregate amount of option shares shall vest on each of May 25, 2023, 2024 and 2025, respectively.
/s/ Keith M. McGahan, attorney-in-fact for Nora E. Brennan
2022-06-23